The invention herein disclosed relates to the anti-HIV action of
uPAR-activators or activated uPAR molecules, the control of chemotaxis
and cell migration by agents interfering with uPAR activation, a method
for determining activated uPAR forms, the use of agents interfering with
uPA/uPAR interaction for the diagnosis or therapy of diseases.
